ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.423G>T (p.Trp141Cys)

dbSNP: rs2143489430
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV002254819 SCV002525912 likely pathogenic Glanzmann thrombasthenia 2022-04-15 reviewed by expert panel curation The missense variant NM_000419.5(ITGA2B):c.423G>T (p.Trp141Cys) has been reported in at least one patient (GT14 in PMID: 25728920), whom displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia. Additionally, alphaIIbbeta3 surface expression was reduced to<5%, as measured by flow cytometry (PP4_strong). GT14 of PMID: 25728920 is compound heterozygous for Trp141Cys and c.2902del (classified as Pathogenic by the PD-EP), confirmation of trans phase was not reported (PM3_supporting). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.879, which is above the ClinGen PD VCEP threshold of >0.7 and predicts a damaging effect on function (PP3). In summary this variant meets criteria to be classified as Likely Pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PP4_strong, PM2_supporting, PM3_supporting, PP3. (VCEP specifications version 2.1)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.